BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3441321)

  • 1. DFP action on rat superior colliculus: localization and role of cholinergic receptors.
    Kasser RJ; Cheney PD
    Neurotoxicology; 1987; 8(4):607-22. PubMed ID: 3441321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of DFP on unit activity in rat superior colliculus.
    Cheney PD; Kasser RJ; Holsapple J
    Neurotoxicology; 1987; 8(4):593-605. PubMed ID: 3441320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic cholinergic modulation of prepulse inhibition of the acoustic startle reflex.
    Jones CK; Shannon HE
    J Pharmacol Exp Ther; 2000 Sep; 294(3):1017-23. PubMed ID: 10945854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral and neurochemical changes in rats dosed repeatedly with diisopropylfluorophosphate.
    Bushnell PJ; Padilla SS; Ward T; Pope CN; Olszyk VB
    J Pharmacol Exp Ther; 1991 Feb; 256(2):741-50. PubMed ID: 1994004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of midbrain presumed dopaminergic neurones by muscarinic cholinergic receptors: an in vivo electrophysiological study in the rat.
    Gronier B; Rasmussen K
    Br J Pharmacol; 1998 Jun; 124(3):455-64. PubMed ID: 9647468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinociceptive effect of diisopropylphosphofluoridate: development of tolerance and lack of cross-tolerance to morphine.
    Costa LG; Murphy SD
    Neurobehav Toxicol Teratol; 1985; 7(3):251-6. PubMed ID: 2993935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-tolerance between muscarinic agonists: role of muscarinic receptors.
    Collins AC; Smolen TN; Smolen A; Medhurst LJ
    Pharmacol Biochem Behav; 1987 Jan; 26(1):173-82. PubMed ID: 3562489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between cholinesterase inhibition and reduction in muscarinic receptors and choline uptake by repeated diisopropylfluorophosphate administration: antagonism by physostigmine and atropine.
    Yamada S; Isogai M; Okudaira H; Hayashi E
    J Pharmacol Exp Ther; 1983 Aug; 226(2):519-25. PubMed ID: 6875862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superior colliculus activation by retinal nicotinic ganglion cells: a 2-deoxyglucose study.
    Pazdernik TL; Cross RS; Mewes K; Samson F; Nelson SR
    Brain Res; 1982 Jul; 243(1):197-200. PubMed ID: 7116156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area.
    Rezayof A; Nazari-Serenjeh F; Zarrindast MR; Sepehri H; Delphi L
    Eur J Pharmacol; 2007 May; 562(1-2):92-102. PubMed ID: 17336285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of diisopropyl phosphorofluoridate (DFP) on CA3 and CA1 responses in rat hippocampus.
    Jones LS; Lapadula DM; Lewis DV; Abou-Donia MB
    Mol Chem Neuropathol; 1990; 13(1-2):1-16. PubMed ID: 2095778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiorespiratory effects produced by activation of cholinergic muscarinic receptors on the ventral surface of the medulla.
    Gillis RA; Walton DP; Quest JA; Namath IJ; Hamosh P; Dretchen KL
    J Pharmacol Exp Ther; 1988 Nov; 247(2):765-73. PubMed ID: 3183970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spatial working and reference memory in rats bred for autonomic sensitivity to cholinergic stimulation: acquisition, accuracy, speed, and effects of cholinergic drugs.
    Bushnell PJ; Levin ED; Overstreet DH
    Neurobiol Learn Mem; 1995 Mar; 63(2):116-32. PubMed ID: 7663885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of oxotremorine, epibatidine, atropine, mecamylamine and naloxone in the tail-flick, hot-plate, and formalin tests in the naked mole-rat (Heterocephalus glaber).
    Dulu TD; Kanui TI; Towett PK; Maloiy GM; Abelson KS
    In Vivo; 2014; 28(1):39-48. PubMed ID: 24425834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced MPTP neurotoxicity after treatment with isoflurophate or cholinergic agonists.
    Hadjiconstantinou M; Hubble JP; Wemlinger TA; Neff NH
    J Pharmacol Exp Ther; 1994 Aug; 270(2):639-44. PubMed ID: 7915317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic receptor binding and behavioral effects of atropoine following chronic catecholamine depletion or acetylcholinesterase inhibition in rats.
    Schallert T; Overstreet DH; Yamamura HI
    Pharmacol Biochem Behav; 1980 Aug; 13(2):187-92. PubMed ID: 7413689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotinic-catecholaminergic interactions in rat brain: evidence for cholinergic nicotinic and muscarinic interactions with hypothalamic epinephrine.
    Roth KA; McIntire SL; Barchas JD
    J Pharmacol Exp Ther; 1982 May; 221(2):416-20. PubMed ID: 7077536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of cholinesterase inhibitors on evoked responses in field CA1 of the rat hippocampus.
    Williamson AM; Sarvey JM
    J Pharmacol Exp Ther; 1985 Nov; 235(2):448-55. PubMed ID: 4057081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bidirectional modulation of visual plasticity by cholinergic receptor subtypes in the frog optic tectum.
    Yu CJ; Butt CM; Debski EA
    Eur J Neurosci; 2003 Mar; 17(6):1253-65. PubMed ID: 12670313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental differences in the analgesia produced by the central cholinergic system.
    Hamm RJ; Knisely JS
    Dev Psychobiol; 1987 May; 20(3):345-54. PubMed ID: 3596060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.